{"id":5709,"date":"2024-02-13T14:45:34","date_gmt":"2024-02-13T19:45:34","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=5709"},"modified":"2026-04-13T12:30:32","modified_gmt":"2026-04-13T16:30:32","slug":"a-revolutionary-approach-to-aptamer-characterization","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/es\/a-revolutionary-approach-to-aptamer-characterization\/","title":{"rendered":"A Revolutionary Approach to Aptamer Characterization"},"content":{"rendered":"

In the dynamic realm of molecular biology, the quest for enhancing diagnostic tools and therapeutic approaches is an ever-evolving journey. One significant breakthrough in this pursuit is the development of the Neomer library, an innovative platform that allows the utilization of identical sequences across various targets. This breakthrough has propelled researchers to delve into a comprehensive characterization of structures within the Neomer library, paving the way for a profound understanding and manipulation of aptamers.<\/p>\n

The Neomer Library and Aptamer Structures:<\/h3>\n

The Neomer library’s groundbreaking feature lies in its ability to deploy the same starting na\u00efve sequences across different targets. This unique characteristic has motivated NeoVentures to invest significant efforts into characterizing the structures within the library comprehensively. The exhaustive endeavor has now yielded a wealth of knowledge, positioning us to delve deeper into the intricacies of these structures immediately after the selection process.<\/p>\n

Similar to antibodies, aptamers derive their functionality from the intricate secondary structures they form. In the case of antibodies, these structures are dictated by the sequence and identity of amino acids in the hypervariable regions. Aptamers, on the other hand, rely on the sequence and identity of nucleotides in their hypervariable regions. The detailed understanding of these structures within the Neomer library has set the stage for a transformative approach to aptamer design and improvement.<\/p>\n

Building a Knowledge Base for Strategic Design:<\/h3>\n

Armed with a comprehensive knowledge base of all possible structures within the Neomer library, we can now assess the nature of structures bound by any given target. The meta-analysis capabilities across this expansive database enable us to formulate hypotheses about ideal structures and strategically design them. This in-silico<\/em> approach to aptamer improvement mirrors the evolutionary principles found in nature.<\/p>\n

Emulating Nature’s Strategy:<\/h3>\n

Nature has perfected the immune system’s ability to screen foreign entities using a relatively small repertoire of na\u00efve antibodies. The selected antibodies undergo recombination to evolve and produce structures with higher binding affinity. Similarly, the Neomer library, with its closed sequence design, enables an in-silico<\/em> approach to immune tolerance. By defining all structures within the library, we have introduced a parallel in-silico<\/em> approach to aptamer enhancement, following nature’s time-tested strategy.<\/p>\n

Partnering for the Future:<\/h3>\n

The implications of these advancements extend beyond the laboratory, as more diagnostic companies join forces to pioneer the next wave of applications in healthcare. Collaborations with these forward-thinking entities are crucial for translating research breakthroughs into real-world solutions.<\/p>\n

We invite you to explore the possibilities and join the revolution in diagnostic applications. Contact us<\/a> for a free consultation, where we aim to understand your vision and collaborate to turn it into reality. Together, we can shape the future of molecular diagnostics and therapeutic interventions.<\/p>","protected":false},"excerpt":{"rendered":"

In the dynamic realm of molecular biology, the quest for enhancing diagnostic tools and therapeutic approaches is an ever-evolving journey. One significant breakthrough in this pursuit is the development of the Neomer library, an innovative platform that allows the utilization of identical sequences across various targets. This breakthrough has propelled researchers to delve into a… Leer m\u00e1s »A Revolutionary Approach to Aptamer Characterization<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":4891,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8,18],"tags":[],"class_list":["post-5709","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers","category-neomers"],"yoast_head":"\nA Revolutionary Approach to Aptamer Characterization<\/title>\n<meta name=\"description\" content=\"A revolutionary approach to aptamer characterization: unleashing the potential of Neomer library to improve aptamers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/es\/a-revolutionary-approach-to-aptamer-characterization\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Revolutionary Approach to Aptamer Characterization\" \/>\n<meta property=\"og:description\" content=\"A revolutionary approach to aptamer characterization: unleashing the potential of Neomer library to improve aptamers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/es\/a-revolutionary-approach-to-aptamer-characterization\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-13T19:45:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T16:30:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Case-studies-images-NeoVentures-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"A Revolutionary Approach to Aptamer Characterization\",\"datePublished\":\"2024-02-13T19:45:34+00:00\",\"dateModified\":\"2026-04-13T16:30:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/\"},\"wordCount\":457,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Case-studies-images-NeoVentures-1.png\",\"articleSection\":[\"Aptamers\",\"Neomer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/\",\"name\":\"A Revolutionary Approach to Aptamer Characterization\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Case-studies-images-NeoVentures-1.png\",\"datePublished\":\"2024-02-13T19:45:34+00:00\",\"dateModified\":\"2026-04-13T16:30:32+00:00\",\"description\":\"A revolutionary approach to aptamer characterization: unleashing the potential of Neomer library to improve aptamers.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Case-studies-images-NeoVentures-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Case-studies-images-NeoVentures-1.png\",\"width\":1200,\"height\":600,\"caption\":\"\\\"Scientist in lab coat examining a petri dish sample through a microscope in a laboratory setting.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/a-revolutionary-approach-to-aptamer-characterization\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Revolutionary Approach to Aptamer Characterization\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Revolutionary Approach to Aptamer Characterization","description":"A revolutionary approach to aptamer characterization: unleashing the potential of Neomer library to improve aptamers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/es\/a-revolutionary-approach-to-aptamer-characterization\/","og_locale":"es_ES","og_type":"article","og_title":"A Revolutionary Approach to Aptamer Characterization","og_description":"A revolutionary approach to aptamer characterization: unleashing the potential of Neomer library to improve aptamers.","og_url":"https:\/\/neoaptamers.com\/es\/a-revolutionary-approach-to-aptamer-characterization\/","og_site_name":"neoaptamers","article_published_time":"2024-02-13T19:45:34+00:00","article_modified_time":"2026-04-13T16:30:32+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Case-studies-images-NeoVentures-1.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Gregory Penner","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"A Revolutionary Approach to Aptamer Characterization","datePublished":"2024-02-13T19:45:34+00:00","dateModified":"2026-04-13T16:30:32+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/"},"wordCount":457,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Case-studies-images-NeoVentures-1.png","articleSection":["Aptamers","Neomer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/","url":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/","name":"A Revolutionary Approach to Aptamer Characterization","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Case-studies-images-NeoVentures-1.png","datePublished":"2024-02-13T19:45:34+00:00","dateModified":"2026-04-13T16:30:32+00:00","description":"A revolutionary approach to aptamer characterization: unleashing the potential of Neomer library to improve aptamers.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Case-studies-images-NeoVentures-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Case-studies-images-NeoVentures-1.png","width":1200,"height":600,"caption":"\"Scientist in lab coat examining a petri dish sample through a microscope in a laboratory setting."},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/a-revolutionary-approach-to-aptamer-characterization\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"A Revolutionary Approach to Aptamer Characterization"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/5709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/comments?post=5709"}],"version-history":[{"count":3,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/5709\/revisions"}],"predecessor-version":[{"id":6491,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/5709\/revisions\/6491"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media\/4891"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media?parent=5709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/categories?post=5709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/tags?post=5709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}